In our cohort, patients with newly introduced drug exposure showed a trend toward lower BP180 ELISA positivity compared with patients without such exposure.
← all excerpts
A Multicenter Analysis of Patients with Bullous Pemphigoid: Clinical Characteristics and Insights into Drug-Associated Disease.
1
—
—